Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
ipilimumab 5 mg/mL IV Soln 40 mL (OTHER 417004632) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 30, 2026 , from http://ppman.hank.ai/transparency/procedure/417004632/by-state?code_type=OTHER
“ipilimumab 5 mg/mL IV Soln 40 mL (OTHER 417004632) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/417004632/by-state?code_type=OTHER. Accessed
June 30, 2026 .
“ipilimumab 5 mg/mL IV Soln 40 mL (OTHER 417004632) by State,” HANK Price Transparency ,
accessed June 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/417004632/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
417004632 — Ipilimumab 5 mg/mL IV Soln 40 Ml
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$32,504
National median
$10,414 – $85,692
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 417004632 (OTHER), with interquartile range
State Median p25 p75
CA $32,504 $10,414 $85,692